H
Hervolution Therapeutics
Biotech & Life Sciences · Copenhagen, Denmark · Founded 2011
Immunotherapies targeting dark genome HERV antigens. MoreLess
Operator of a biotechnology company intended to treat cancer by targeting tumor viruses within the human genome. The company offers broad and curative cancer therapy in combination with immune checkpoint inhibitors, enabling medical researchers to easily find treatment for cancer using adaptive immune therapy.
Talent graph
Hervolution Therapeutics's talent
Source: Dealroom Talent Intelligence.
Investors
3 investors on Hervolution Therapeutics's cap table
Sourced from Dealroom's funding and investor records.



Global footprint
Where Hervolution Therapeutics has talent and traffic
team presence
Market sentiment
What the market is saying about Hervolution Therapeutics
An AI-synthesized read of the highest-engagement posts about Hervolution Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Hervolution Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.